top of page

Degefaye Zelalem Anlay successfully defended his PhD!

5 uur geleden
1 minuten om te lezen

On September 2, 2026, Degefaye Zelalem Anlay successfully defended his joint PhD at the University of Antwerp and Vrije Universiteit Brussel, entitled: “Deprescribing medications in nursing homes: Using big data to study real-world implementation and effects on end-of-life-relevant outcomes.”


His research provides important insights into deprescribing potentially inappropriate medications in nursing home residents, particularly those with a limited life expectancy. Although deprescribing can help align medication use with residents’ changing clinical needs and care goals, evidence on its implementation and effects in everyday nursing home practice remains limited.

Using systematic reviews, linked healthcare and nursing home data, qualitative interviews and advanced analytical approaches, his research examined how deprescribing is implemented in practice, which barriers and enablers healthcare professionals experience, and how changes in medication use are associated with outcomes relevant to end-of-life care.


The findings show that deprescribing is not yet sufficiently embedded in routine practice. At the same time, the research provides promising evidence that deprescribing certain medications can be done safely. In particular, deprescribing proton pump inhibitors was not associated with worse quality-of-life-related outcomes and was associated with fewer hospitalisations.


Finally, the research highlights the opportunities of using large-scale linked healthcare data to study medication use in nursing home residents, while also identifying important challenges related to timely and efficient access to these data.


You can find the full PhD thesis here.



 
 
 

Opmerkingen


Recent Posts

© 2023 by Kathy Schulders. Proudly created with Wix.com 

  • Grey Twitter Icon
bottom of page